Navigation Links
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
Date:4/25/2012

PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting results for the second quarter of fiscal year 2012 with net earnings of $0.94 per diluted share up 9 percent from $0.86 per diluted share in the second quarter of fiscal year 2011.  The results for the second quarter of fiscal year 2012 include a $2.5 million or $0.02 per diluted share restructuring charge associated with realigning resources to address growth prospects in emerging markets. The company generated $720 million in revenues during the quarter, up 11 percent from the prior-year period, and ended the period with a $2.7 billion backlog, up 18 percent from the same point in fiscal year 2011.

"Our company generated healthy growth during the quarter in revenues and net orders, including two large orders for proton therapy systems which contributed to a strong increase in our backlog," said Tim Guertin, president and CEO of Varian Medical Systems.  "Results on margins for the quarter were mixed, with solid gains in our X-Ray Products business more than offset by reduced margins in our Oncology business principally because of significant growth in revenues in emerging markets where margins and tax rates are lower."  Gross margins were also impacted by nearly a point from revenues for the company's ongoing Scripps proton system installation which are being accounted for under the percentage of completion zero-profit method.

The company ended the second quarter with $617 million in cash and cash equivalents and $162 million of debt.  Days sales outstanding for the quarter was 83, up 4 from the same time period last year.

Oncology Systems
Oncology Systems' second quarter revenues totaled $565 million, up 11 percent from the same period of fiscal year 2011.  Second-quarter net orders were $565 million, up 9 percent, wit
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility
2. Varian Medical Systems Announces Agreement to Acquire InfiMed, Inc.
3. Varian Medical Systems to Exhibit X-Ray Tubes and Flat Panel Detector Technology Enhancements to Improve Digital Imaging at the ECR Annual Meeting
4. Varian Medical Systems Receives FDA 510(k) Clearance for Use of Transponder to Monitor Motion During Radiotherapy Anywhere in Body
5. Varian Medical Systems to Equip New Proton Treatment Center in Russia
6. Varian Medical Systems Uses SAP to Support Sustainability and Compliance With REACH and RoHS
7. Varian Medical Systems Books $77 Million Order to Equip Proton Treatment Center in Saudi Arabia
8. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2012
9. Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
10. Varian Medical Systems Establishes Radiotherapy Training Center and Clinical Help Desk in Tokyo, Japan
11. Varian Medical Systems Receives FDA 510(k) Clearance for Software that Speeds Up Radiotherapy Treatment Planning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015  Pharmaceutic Labs announces its official status ... of the FDA,s Drug Quality and Security Act. ... subject to Current Good Manufacturing Practice (CGMP) and ... the highest standards of CGMP 21 CFR Part ... comply with FDA regulations and ensure patient safety, ...
(Date:5/28/2015)... RARITAN, N.J. , May 28, 2015  Janssen ... today announced the initiation of CALLISTO, a new comprehensive ... in patients with active cancer. The studies are evaluating ... blood clots in patients with a wide range of ... the risk of venous thromboembolism (VTE), which is a ...
(Date:5/28/2015)... May 28, 2015  Cardinal Health today announced that ... & Johnson,s Cordis business for $1.944 billion in cash ... with relevant works councils and trade unions. The transaction ... States and key non-U.S. countries towards the ... customary closing conditions. Headquartered in ...
Breaking Medicine Technology:New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 4New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 5New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 6New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 7New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 8New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 9New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 10New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 11New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 12Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4
... Aug. 20 Do you currently have a study,that ... sites,recruitment tools and a budget for media but still ... is an extra set of hands to help,your sites ... assistance and consultation., "Through our Argonauta Assist(TM) service," ...
... SYDNEY, Australia, Aug. 20 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis ... 3 clinical trial evaluating the long term safety ... no serious,adverse events attributed to the drug following ... 123 subjects started treatment with 320 mg Bronchitol ...
Cached Medicine Technology:Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3
(Date:5/28/2015)... Sacramento, PA (PRWEB) May 28, 2015 ... wishes and adventures. Each item on the ... absolutely impossible events, experiences and tasks that the owner ... is no right or wrong when it comes to ... starting a business, writing poems, publishing a book, seeing ...
(Date:5/28/2015)... Palmetto, FL (PRWEB) May 28, 2015 ... released a case study featuring Healthcare IQ. Members of ... Healthcare IQ senior management team to develop the case ... arena of healthcare analytics. , The case study, ‘Healthcare ... chronicles Healthcare IQ from its beginning as a hospital ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Orem, UT—Dymicron, ... in-human surgeries using their unique Triadyme-C cervical total disc ... surgeon Dr. William D. Smith at the American Institute ... “The patients are responding well to the implantation of ... of AIMIS Spine Center and Chief of Neurosurgery for ...
(Date:5/28/2015)... 2015 Aureus Medical Group (web: aureuslocumtenens.com), ... jobs, has announced that it will participate as an ... National Conference to be held June 9-14, 2015 in ... programming, networking opportunities, and exhibits with products and services. ... division will be available to speak with attendees ...
(Date:5/28/2015)... NY (PRWEB) May 28, 2015 Peggy J. ... Chief Delegate to the American Physical Therapy Association House of ... the Delegation at their Delegate Assembly. This will be ... of Delegates serves as coordinator and principle spokesperson for the ... The Board of Directors or Delegate Assembly may direct the ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
... Treat Diseases (HTDS) www.htdsmedical.com is pleased to ... Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope). ... corporation; HTDS Enterprises, Inc., which is the parent company ... million USD on an all-stock basis. The company will ...
... Misonix, Inc. (Nasdaq: MSON ), a developer ... Europe is used for the ablation of tumors and ... a new, three year, exclusive distribution agreement with privately-held ... Saba, Israel, for the distribution of the SonaStar(TM) Ultrasonic ...
... Consumer Watchdog sent a letter to Senator ... expressing their profound disappointment that consumer advocates had ... the Massachusetts senator to formulate health care reform ... recent national polls showing the public overwhelming opposed ...
... Well Asthma is Controlled in New EnglandPROVIDENCE, R.I., Feb. ... (ALANE) has partnered with QualityMetric Incorporated of Lincoln, Rhode ... that will help asthma sufferers learn how well their ... the results with their physician.The Asthma Control Test(TM) (ACT(TM)) ...
... QINGDAO, China and ROCKVILLE, Md., Feb. 20 ... SYUT , "Synutra"), a leading infant formula,company ... seller of nutritional products,for infants, children and ... of certain production permit numbers in a ...
... Inc., (OTC Bulletin Board: EFSF) an emerging healthcare ... dermatology, environmental and nutraceutical products, outlined its growth ... 2010 during its regularly scheduled monthly investor call, ... intends to increase revenues by improving the visibility ...
Cached Medicine News:Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 2Health News:Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China 3Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:Consumer Watchdog to U.S. Senate: Don't Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone 2Health News:American Lung Association of New England Launches Online Asthma Control Test 2Health News:American Lung Association of New England Launches Online Asthma Control Test 3Health News:American Lung Association of New England Launches Online Asthma Control Test 4Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 2Health News:Synutra Issues Statement Regarding Market Rumors on Revocation of its Production Certification 3Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 2Health News:eFoodSafety.com Provides Revenue Guidance for FY 2010 3
Tested by surgeons for functionality and ergonomy. Uses the Medifix C1301-1CCD camera head....
Large image and wide angle design for transurethral examination and treatment of the ureter and renal pelvis....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... Boston Keratoprosthesis consists of two plastic parts ... is then sutured into the patient's cornea ... has been under development since the 1960s ... FDA clearance in 1992. About 600 implantations ...
Medicine Products: